Agilent Technologies, Inc. (A)
Market Cap | 39.84B |
Revenue (ttm) | 6.50B |
Net Income (ttm) | 1.41B |
Shares Out | 287.33M |
EPS (ttm) | 4.81 |
PE Ratio | 28.80 |
Forward PE | 25.19 |
Dividend | $0.94 (0.68%) |
Ex-Dividend Date | Jul 2, 2024 |
Volume | 416,750 |
Open | 138.28 |
Previous Close | 137.31 |
Day's Range | 137.50 - 139.74 |
52-Week Range | 96.80 - 155.35 |
Beta | 1.05 |
Analysts | Buy |
Price Target | 140.56 (+1.39%) |
Earnings Date | Aug 21, 2024 |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]
Financial Performance
In 2023, Agilent Technologies's revenue was $6.83 billion, a decrease of -0.22% compared to the previous year's $6.85 billion. Earnings were $1.24 billion, a decrease of -1.12%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for A stock is "Buy." The 12-month stock price forecast is $140.56, which is an increase of 1.39% from the latest price.
News
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of Californ...
Airplane engines are in short supply. The business of fixing older ones is booming
Engine repair shops have swelled to a $58 billion business, according to Alton Aviation Consultancy, and are cash cow for engine makers like GE Aerospace.
Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Agilent Technologies focuses on growing biopharma, PFAS testing, and advanced materials for semiconductors. Recent acquisitions and divestitures show mixed results, with potential for technological en...
These Analysts Boost Their Forecasts On Agilent After Strong Earnings
Agilent Technologies, Inc. A posted better-than-expected third-quarter earnings and issued upbeat fourth-quarter guidance on Wednesday.
Agilent Technologies, Inc. (A) Q3 2024 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A) Q3 2024 Earnings Conference Call August 21, 2024 4:30 PM ET Company Participants Conference Call Participants Operator Ladies and gentlemen, welcome to the Agilent...
Agilent beats quarterly results on strong demand from biotech clients
Agilent Technologies on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and equipment used in clinical studies.
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.58 billion for the third quarter ended July 31, 2024, a decline of 5.6% reported and 4.4% core(1)...
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass ...
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid ...
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent has acquired Sigsense Technologies, a startup that uses artificial intelligence and power monitoring to optimize lab operations.
Agilent to buy contract drug manufacturer Biovectra for $925 million
Agilent Technologies said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
Agilent to Acquire North American CDMO BIOVECTRA
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent has signed a definitive agreement to acquire BIOVECTRA, a leading contract development and manufacturing organization, for $925 million.
Agilent to Announce Third-Quarter Fiscal Year 2024 Financial Results Aug. 21
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the stock market closes on Aug. 21. In addition...
Agilent Names Bret DiMarco Chief Legal Officer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced Bret DiMarco has been named to lead the company's global legal organization as senior vice president and chie...
Agilent's ESG Report Highlights Expansion of Solutions to Help Labs Manage Their Environmental Footprint
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today released the company's annual ESG report, showcasing a comprehensive and growing set of sustainable solutions that enabl...
Agilent Technologies, Inc. (A) Jefferies 2024 Global Healthcare Conference (Transcript)
Agilent Technologies, Inc. (NYSE:A) Jefferies 2024 Global Healthcare Conference June 5, 2024 8:30 AM ET Company Participants Robert McMahon - Senior Vice President and Chief Financial Officer Confere...
Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
ePrep and Agilent Announce New Distribution Partnership for the ePrep(R) ONE Chromatography Sample Preparation Workstation
San Francisco, California--(Newsfile Corp. - June 4, 2024) - ePrep is delighted to announce a new partnership with Agilent - a global leader in technology platforms for analytical laboratories - for ...
Agilent Announces Cutting-Edge Advances in GC/MS and LC/Q-TOF Technology at ASMS 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) is introducing two new products at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. The Agilent 7010D Triple ...
Agilent Technologies, Inc. (A) Q2 2024 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A) Q2 2024 Results Conference Call May 29, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Padraig McDonnell - President & Chief Executive Off...
Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.57 billion for the second quarter ended April 30, 2024, a decline of 8.4% reported and 7.4...
Monthly Options Series: Earn A Potentially Consistent 10% Income (June 2024)
We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate a sustainable and repeatable income strategy for Opti...
Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Hans E. Bishop, president and co-founder of Altos Labs, has stepped down from serving on Agilent's board ...
Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence
New instrument delivers the full power and capability of Agilent GCs in a compact design SANTA CLARA, Calif. , May 23, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) proudly announces the ...
Agilent Announces Cash Dividend of 23.6 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on July 24, 2024, to all shareholde...